Color announces Series E financing, at a valuation of $4.6 billion, to accelerate expansion of accessible and equitable public health infrastructure
Sema4, a Disruptive AI-driven Genomic & Clinical Data Platform Company, to Combine with CM Life Sciences to Accelerate Growth